Poster Dianne L, Postek Michael T, Obeng Yaw S, Kasianowicz John J, Cowan Troy E, Horn Norman R, Miller C Cameron, Martinello Richard A
National Institute of Standards and Technology, Gaithersburg, MD 20899, USA.
University of South Florida, Tampa, FL 33612, USA.
J Res Natl Inst Stand Technol. 2022 Mar 25;126:126055. doi: 10.6028/jres.126.055. eCollection 2021.
The development of an international, precompetitive, collaborative, ultraviolet (UV) research consortium is discussed as an opportunity to lay the groundwork for a new UV commercial industry and the supply chain to support this industry. History has demonstrated that consortia can offer promising approaches to solve many common, current industry challenges, such as the paucity of data regarding the doses of ultraviolet-C (UV-C, 200 nm to 280 nm) radiation necessary to achieve the desired reductions in healthcare pathogens and the ability of mobile disinfection devices to deliver adequate doses to the different types of surfaces in a whole-room environment. Standard methods for testing are only in the initial stages of development, making it difficult to choose a specific UV-C device for a healthcare application. Currently, the public interest in UV-C disinfection applications is elevated due to the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the respiratory coronavirus disease 19 (COVID-19). By channeling the expertise of different UV industry stakeholder sectors into a unified international consortium, innovation in UV measurements and data could be developed to support test methods and standards development for UV healthcare equipment. As discussed in this paper, several successful examples of consortia are applicable to the UV industry to help solve these types of common problems. It is anticipated that a consortium for the industry could lead to UV applications for disinfection becoming globally prolific and commonplace in residential, work, business, and school settings as well as in transportation (bus, rail, air, ship) environments. Aggressive elimination of infectious agents by UV-C technologies would also help to reduce the evolution of antibiotic-resistant bacteria.
本文讨论了建立一个国际性、竞争前、协作性的紫外线（UV）研究联盟的事宜，认为这是为新兴的紫外线商业产业及其供应链奠定基础的契机。历史表明，联盟能够提供可行的方法来解决当前行业面临的诸多共同挑战，比如缺乏关于实现医疗保健病原体预期减少所需的紫外线C（UV-C，200纳米至280纳米）辐射剂量的数据，以及移动消毒设备在全室环境中对不同类型表面输送足够剂量的能力。测试的标准方法尚处于初步发展阶段，这使得难以选择适用于医疗保健应用的特定UV-C设备。目前，由于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的传播，即导致冠状病毒病19（COVID-19）的病毒，公众对UV-C消毒应用的关注度有所提高。通过将紫外线行业不同利益相关方的专业知识汇聚到一个统一的国际联盟中，可以推动紫外线测量和数据方面的创新，以支持紫外线医疗设备的测试方法和标准制定。如本文所讨论的，联盟的几个成功范例适用于紫外线行业，有助于解决这类常见问题。预计该行业联盟将促使紫外线消毒应用在全球范围内大量涌现，并在住宅、工作场所、商业场所、学校环境以及交通（公共汽车、铁路、航空、船舶）环境中变得司空见惯。通过UV-C技术积极消除传染源也将有助于减少抗生素耐药细菌的进化。
